Page last updated: 2024-08-24

imiquimod and mupirocin

imiquimod has been researched along with mupirocin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, JQ; Chen, XY; Cui, YZ; Fu, NC; Landeck, L; Man, XY; Wang, ZY; Xu, F; Yan, BX; Yang, XY; Zhou, Y1

Other Studies

2 other study(ies) available for imiquimod and mupirocin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase.
    Cell communication and signaling : CCS, 2022, 11-22, Volume: 20, Issue:1

    Topics: Animals; Humans; Imiquimod; Isoleucine-tRNA Ligase; Mice; Mice, Inbred C57BL; Mupirocin; Psoriasis; Skin Diseases

2022